A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.
Medical advances mean many more people are surviving cancer and living for years or decades with its after effects. Here's how they are navigating life after treatment.
On the heels of the surgeon general's warning about the cancer risks of alcohol, there's growing consensus that less is better. But how much is enough? Here's what the experts recommend.
Living through cancer can change you — it puts pressure on everything, from your relationships to your career to your sense of self. Share how it's affected you and advice you'd give to others.
Loss of social support after a cancer diagnosis is a surprisingly common experience, social workers and cancer patients say. For young cancer survivors, it is a particularly difficult part of the disease.
Pediatric cancer survival rates are a crowning medical achievement. But the impact of missing school is a less-discussed side effect children then face.
A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are also getting diagnosed, and at younger ages.
Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
Rasha Kowalewski was struck by the extra care a nurse gave her mom, which allowed Kowalewski to experience a moment of comfort during one of the hardest times of her life.
The largest nationwide study of cancer risk and outcomes in Black women is currently enrolling participants between 25 and 55 who have never been diagnosed with cancer. Georgia is one of 20 states enrolling for the 30-year study.
Buckingham Palace hasn't said what type of cancer Charles had or if he's finished treatment. It said he'll make a public visit to a cancer clinic Tuesday and will welcome Japan's emperor in June.
Drug company reps commonly visit doctors to talk about new medications. A team of economists wanted to know if that helps patients live longer. They found that for cancer patients, the answer is no.